UnitedHealth Group (NYSE:UNH) Stock Price Down 0.5%

UnitedHealth Group Incorporated (NYSE:UNH) dropped 0.5% during trading on Thursday . The stock traded as low as $478.00 and last traded at $482.53. Approximately 1,398,788 shares were traded during trading, a decline of 66% from the average daily volume of 4,159,448 shares. The stock had previously closed at $484.72.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research note on Thursday, April 4th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Piper Sandler upped their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Three investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $571.40.

UnitedHealth Group Trading Down 0.5 %

The business has a 50-day moving average price of $489.67 and a 200-day moving average price of $509.89. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $443.72 billion, a P/E ratio of 29.49, a PEG ratio of 1.46 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the firm earned $6.26 EPS. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of UNH. Verdence Capital Advisors LLC lifted its holdings in UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after buying an additional 342 shares during the period. Bellecapital International Ltd. increased its position in UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after purchasing an additional 193 shares during the period. Rise Advisors LLC lifted its position in shares of UnitedHealth Group by 326.0% in the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after purchasing an additional 163 shares during the period. Gradient Investments LLC increased its position in shares of UnitedHealth Group by 6.3% during the fourth quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock worth $44,370,000 after buying an additional 5,023 shares during the period. Finally, Vanguard Personalized Indexing Management LLC lifted its holdings in UnitedHealth Group by 7.9% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock valued at $39,802,000 after buying an additional 5,537 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.